Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer - Wikidata - wikimedia - TriplyDB

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

http://www.wikidata.org/entity/Q35230326

about

Interaction of tumor cells with the microenvironment Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer Role of EMT in Metastasis and Therapy Resistance Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1-Jagged1-KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision Epithelial to Mesenchymal Transition in a Clinical Perspective Mitochondrial ROS and cancer drug resistance: Implications for therapy A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine Pancreatic cancer stem cells: emerging target for designing novel therapy Sheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transition The role of Snail in prostate cancer Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance The emerging molecular machinery and therapeutic targets of metastasis Human correlates of provocative questions in pancreatic pathology Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1 Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells Nuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditions Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells Inhibition of inducible heat shock protein-70 (hsp72) enhances bortezomib-induced cell death in human bladder cancer cells Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotini DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents

P2860

Q21245506-DA386620-39B4-4AA2-9D59-72671A22AC7A Q24324198-6F93E05B-34A1-4AF8-99F4-6A704ADC7FF2 Q24617121-3F44A63C-42FE-4851-AABB-705016747C40 Q26740619-74681A65-F2B6-4750-B6D8-6E4D848AD98B Q26741846-AA891414-8C58-4D42-B266-F33512045C34 Q26772923-35D85994-4022-495B-9019-283A52B7C7E7 Q26773015-7A0A1F25-582E-4A7D-BE6C-144488940F0D Q26775618-D7C798A1-8D39-45CC-806F-F90C03F34A11 Q26783554-E4D90BD2-193B-4849-A72C-79A02BCE3045 Q26798106-C7CFA264-F880-4E6B-AD28-DD3E6A9DDF3F Q26799171-23018D87-54F1-4A4C-809E-F60AFAA77F0F Q26799987-455BBA8B-3B62-42B2-8B54-DF8B69314793 Q26800337-D4BB08FA-0294-4EFF-B5B1-03EA2B33F371 Q26863365-0B76A2F4-A56F-42B0-84D6-3BF8DC7CF3FA Q26864979-E7783943-4403-4117-AE1A-C453CD876097 Q27004557-C3030252-44F3-42D3-9CAF-5942BDA8C55D Q27012236-BFD5D6B5-F3BF-4213-8FA8-662784B51A60 Q27015111-AE3B8122-4CC1-4D7E-AE7F-1D7436248CEC Q27022207-28CAB357-5132-46DC-813E-C79ECC4D5B00 Q27023576-33680F9D-71FF-41E8-9B86-1808C8924A45 Q27853047-9F496070-F2BF-42CC-AD70-06A0F0470BF4 Q28066130-C77F2019-E3B3-4054-910D-BDA53F183BAD Q28066454-6042D841-CF33-4EC9-8959-8B7EBC546C50 Q28386389-5F5D3C29-0496-4218-A7DD-472AB46A7A2C Q28468512-08259EC4-DDEF-43CE-8DE1-65AC28AE3F7F Q28468669-62B5E439-E941-4D2C-AA16-963BCCE36D95 Q28476694-AF6570F2-61E4-4D6E-81BA-4D3E9242CF98 Q28485142-EFA55B64-9FC6-42B9-9BB8-A79414B6FD61 Q28534720-044CE4DE-C1E9-4234-9A23-5BAB6B84BFF6 Q28535288-48555C61-D940-42DD-9FAE-73F3962AF3FF Q28542879-DDF14048-83FD-4ECF-9F59-17BD8B543CF9 Q28546067-A09DB585-78BB-4B93-AAFA-832DB149D4D6 Q28547017-4265C728-34B8-4162-9D4B-5D3FCCA2A6B7 Q28552789-625A355D-D584-412A-988A-42353B8A0A87 Q30502172-DEC46250-9C20-4C78-81AF-40B783DB8F29 Q30641525-5DE5CCC3-86B1-47C4-A6A9-F1D4C5F7E68A Q30659572-BB4C2605-7695-4299-A8B5-E32D3E126DAB Q33416585-6C311EEE-5373-4F35-B0C8-8DB3BC285C11 Q33582958-318CD800-D2D5-455B-9725-03808D81936C Q33704284-32FA1133-13B2-491F-BF51-22639A33CDA9

P2860

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

http://www.wikidata.org/entity/Q35230326

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@ast

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@en

type

label

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@ast

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@en

prefLabel

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@ast

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@en

P1433

Q35230326-4E526783-A710-46CF-BBDC-5F7B1988860E

P1476

Q35230326-604DF423-1523-425D-86CE-F1860A4CCCCD

P2093

Q35230326-08C08264-2B54-481F-8FFB-389428D5E090

Q35230326-2AE00F8D-18DE-45B9-8DFC-147F558F894C

Q35230326-38AB85FF-7D6B-4A31-8DA2-7D2292F7907D

Q35230326-461ECCFC-A2B1-4535-AD40-F193E9618011

Q35230326-5D30AD3E-3B15-4DC7-8DFB-2DA8D21654A9

Q35230326-607DEF47-E54B-4A73-9EA4-7A0F3A177ED9

Q35230326-9413F33F-EABF-49D5-A8C2-C68053365FCA

Q35230326-A58A7C95-EC95-49D2-830D-2EF747C8D73D

Q35230326-CCE665B6-288E-4CBE-BF6D-A777A67B936D

Q35230326-F9895587-8009-4275-B75A-DD33C253DD80

P2860

Q35230326-003EC279-0FA4-457A-B54D-E119B28F5A20

Q35230326-0223966B-CBA1-451E-A6C7-83DEF2F1E7F6

Q35230326-064702DB-D5E9-4023-82B8-B129AF7C0063

Q35230326-121C0E0B-1D1A-4006-8ECF-FE98D54F08FB

Q35230326-16C3FECA-FFF7-47FF-83EE-02044A06E014

Q35230326-1EA64D92-6967-4EB6-A48C-6435C028D30C

Q35230326-2872E39D-2C75-4BB4-9069-F3C0E34E8596

Q35230326-3CF87EF4-9F04-4016-ABF5-468E3AA30BD8

Q35230326-3F84E570-D0CD-4756-8C93-9EE7B5FE19B1

Q35230326-44E4BC75-9683-4A2F-8022-D73AC234FFC4

P304

Q35230326-2C6B3907-EA45-4AC0-92C7-804620F5DAB9

P31

Q35230326-EB68533C-AF13-4D5C-B213-45EBD5930301

P356

Q35230326-ED723EB9-86FE-40D6-9212-80977A95C22D

P407

Q35230326-9E1F8ACA-05B6-4D05-A331-8BD4BDBE149C

P433

Q35230326-60F1B4E2-7012-4342-94EB-DAC8DA260B63

P478

Q35230326-3692C16C-BC3B-4BEC-BA0F-149B6E6C010A

P577

Q35230326-7326D716-08B8-490E-8756-25DD514CF697

P698

Q35230326-5ED34E55-2B12-458F-A62F-0D70DF97C0A5

P932

Q35230326-95DF3A63-6389-43C8-88B8-B47B405110E9

P356

0008-5472.CAN-08-2819

P1433

Cancer Research

P1476

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer

@en

P2093

Craig D Logsdon

http://www.w3.org/2001/XMLSchema#string

David J McConkey

http://www.w3.org/2001/XMLSchema#string

Gary E Gallick

http://www.w3.org/2001/XMLSchema#string

Huamin Wang

http://www.w3.org/2001/XMLSchema#string

James L Abbruzzese

http://www.w3.org/2001/XMLSchema#string

Keith F Fournier

http://www.w3.org/2001/XMLSchema#string

Lauren Marquis

http://www.w3.org/2001/XMLSchema#string

Thiruvengadam Arumugam

http://www.w3.org/2001/XMLSchema#string

Vijaya Ramachandran

http://www.w3.org/2001/XMLSchema#string

Woonyoung Choi

http://www.w3.org/2001/XMLSchema#string

P2860

Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress

S100P promotes pancreatic cancer growth, survival, and invasion

Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis

Cluster analysis and display of genome-wide expression patterns

MAL2, a novel raft protein of the MAL family, is an essential component of the machinery for transcytosis in hepatoma HepG2 cells

SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Gene expression patterns in pancreatic tumors, cells and tissues.

P304

5820-5828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-2819

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19584296

http://www.w3.org/2001/XMLSchema#string

P932

4378690

http://www.w3.org/2001/XMLSchema#string